[181]
HUMAN STOMACH CANCER TISSUE ARRAY For Research Use Only
[136,9 KB]
From [www.proteinbiotechnologies.com] Last viewed: 06.07.2006
1672 Main St. Ste. E #264 • Ramona, CA 92065 • Tel: 760.789.8928 • Fax: 760.789.8929 • Toll Free: 800.475.1955 • www.proteinbiotechnologies.com
HUMAN STOMACH CANCER TISSUE ARRAY
Catalog Number:
TMA-094
Each two (2) dots from two different tissue spots represents one single specimen that was pathologically
selected and confirmed (Gastric ulcer tissue array)
Cases: 14
Cores: 24
Diameter: 1.5mm
Thickness: 5 µm
Standard IHC: CK confirmed
Layout : 4 x 6
1
2
3
4
5
6
A
1
2
3
4
5
6
B
7
8
9
10
11
12
C
13
14
15
16
17
18
D
19
20
21
22
23
24
Core No. Location Tissue
Diagnosis
Grade Sex Age
01
A1
Stomach
Chronic gastric ulcer ...
[182]
TAXOTERE RECEIVES US FDA APPROVAL FOR USE IN ADVANCED STOMACH ...
[136,8 KB]
From [newsdesk.se] Last viewed: 25.06.2006
TAXOTERE
®
RECEIVES U.S. FDA APPROVAL FOR USE IN ADVANCED STOMACH
CANCER
TAXOTERE
®
-based regimen demonstrates a 23% reduction in the risk of mortality
in patients with advanced stomach cancer
Paris, France – March 23, 2006 – Sanofi-aventis announced today that following a priority review of
the supplemental new drug application (sNDA), the U.S. Food and Drug Administration (FDA) has
approved TAXOTERE
®
(docetaxel) Injection Concentrate in combination with cisplatin and
5-fluorouracil for the treatment of patients with advanced stomach (gastric) cancer , including cancer of
the gastro esophageal (GE) junction, who have not received prior chemotherapy for advanced disease.
This is the first FDA approval of an advanced stomach cancer treatment demonstrating a survival
advantage in more than a decade, thereby offering physicians ...
[183]
TAXOTERE® RECEIVES US FDA APPROVAL FOR USE IN ADVANCED STOMACH CANCER
[95,8 KB]
From [www.sanofi-aventis.us] Last viewed: 25.06.2006
TAXOTERE® RECEIVES U.S. FDA APPROVAL FOR USE
IN ADVANCED STOMACH CANCER
TAXOTERE®-based regimen demonstrates a 23% reduction in the risk of mortality
in patients with advanced stomach cancer
Bridgewater, NJ – March 23, 2006 – Sanofi-aventis announced today that following a
priority review of the supplemental new drug application (sNDA), the U.S. Food and
Drug Administration (FDA) has approved TAXOTERE® (docetaxel) Injection
Concentrate in combination with cisplatin and 5-fluorouracil for the treatment of patients
with advanced stomach (gastric) cancer , including cancer of the gastro esophageal (GE)
junction, who have not received prior chemotherapy for advanced disease. This is the
first FDA approval of an advanced stomach cancer treatment demonstrating a survival
advantage in more than a decade, thereby offering physicians and their patients an
important new option for treating ...
[184]
HUMAN STOMACH CANCER TISSUE ARRAY
[182,6 KB]
From [www.proteinbiotechnologies.com] Last viewed: 25.06.2006
1672 Main St. Ste. E #264 • Ramona, CA 92065 • Tel: 760.789.8928 • Fax: 760.789.8929 • Toll Free: 800.475.1955 • www.proteinbiotechnologies.com
HUMAN STOMACH CANCER TISSUE ARRAY
Catalog Number:
TMA-099
Each dot represents a DISEASED or NORMAL tissue spot from specimen that was selected and
pathologically confirmed (Carcinoma of stomach , liver and rectum tissue array)
Cases: 45
Cores: 48
Diameter: 1.5mm
Thickness: 5 µm
Standard IHC: P53 confirmed
Layout : 6 x 8
1
2
3
4
5
6
7
8
A
1
2
3
4
5
6
7
8
B
9
10
11
12
13
14
15
16
C
17
18
19
20
21
22
23
24
D
25
26
27
28
29
30
31
32
E
33
34
...
[185]
HUMAN STOMACH CANCER TISSUE ARRAY
[183,1 KB]
From [www.proteinbiotechnologies.com] Last viewed: 25.06.2006
1672 Main St. Ste. E #264 • Ramona, CA 92065 • Tel: 760.789.8928 • Fax: 760.789.8929 • Toll Free: 800.475.1955 • www.proteinbiotechnologies.com
HUMAN STOMACH CANCER TISSUE ARRAY
Catalog Number:
TMA-096
This is a COMBINATION ARRAY PANEL from diseased, normal and adjacent (1.5cm) to specimen that
was selected and pathologically confirmed ( stomach adenocarcinoma tissue array)
Cases: 21
Cores: 63
Diameter: 1.5mm
Thickness: 5 µm
Standard IHC: PCNA confirmed
Layout : 7 x 9
1
2
3
4
5
6
7
8
9
A
1
2
3
4
5
6
7
8
9
B
10
11
12
13
14
15
16
17
18
C
19
20
21
22
23
24
25
26
27
D
28
29
30
31
32
33
34
...
[186]
HUMAN STOMACH CANCER TISSUE ARRAY
[184,6 KB]
From [www.proteinbiotechnologies.com] Last viewed: 25.06.2006
1672 Main St. Ste. E #264 • Ramona, CA 92065 • Tel: 760.789.8928 • Fax: 760.789.8929 • Toll Free: 800.475.1955 • www.proteinbiotechnologies.com
HUMAN STOMACH CANCER TISSUE ARRAY
Catalog Number:
TMA-097
This is a COMBINATION ARRAY PANEL from diseased, normal and adjacent (1.5cm) to specimen that
was selected and pathologically confirmed ( stomach adenocarcinoma tissue array)
Cases: 21
Cores: 63
Diameter: 1.5mm
Thickness: 5 µm
Standard IHC: L-CK confirmed
Layout : 7 x 9
1
2
3
4
5
6
7
8
9
A
1
2
3
4
5
6
7
8
9
B
10
11
12
13
14
15
16
17
18
C
19
20
21
22
23
24
25
26
27
D
28
29
30
31
32
33
34
...
[187]
HUMAN STOMACH CANCER TISSUE ARRAY
[184,5 KB]
From [www.proteinbiotechnologies.com] Last viewed: 25.06.2006
1672 Main St. Ste. E #264 • Ramona, CA 92065 • Tel: 760.789.8928 • Fax: 760.789.8929 • Toll Free: 800.475.1955 • www.proteinbiotechnologies.com
HUMAN STOMACH CANCER TISSUE ARRAY
Catalog Number:
TMA-101
Each three (3) dots from three different tissue spots represents one single specimen selected and
pathologically confirmed. (Normal stomach tissue (multi-sites) array)
Cases: 21
Cores: 63
Diameter: 1.5mm
Thickness: 5 µm
Standard IHC: Actin confirmed
Layout : 7 x 9
1
2
3
4
5
6
7
8
9
A
1
2
3
4
5
6
7
8
9
B
10
11
12
13
14
15
16
17
18
C
19
20
21
22
23
24
25
26
27
D
28
29
30
31
32
33
34
35 ...
[188]
HUMAN STOMACH CANCER TISSUE ARRAY
[183,2 KB]
From [www.proteinbiotechnologies.com] Last viewed: 25.06.2006
1672 Main St. Ste. E #264 • Ramona, CA 92065 • Tel: 760.789.8928 • Fax: 760.789.8929 • Toll Free: 800.475.1955 • www.proteinbiotechnologies.com
HUMAN STOMACH CANCER TISSUE ARRAY
Catalog Number:
TMA-102
Each dot represents a NORMAL tissue spot from one individual specimen that was selected and
pathologically confirmed
Cases: 70
Cores: 72
Diameter: 1.5mm
Thickness: 5 µm
Standard IHC: Actin confirmed
Layout : 8 x 9
1
2
3
4
5
6
7
8
9
A
1
2
3
4
5
6
7
8
9
B
10
11
12
13
14
15
16
17
18
C
19
20
21
22
23
24
25
26
27
D
28
29
30
31
32
33
34
35
36
E
37
38
39
...
[189]
TRENDS IN MORTALITY FROM STOMACH CANCER (ICD10 C16 ICD9 151 ...
[30,3 KB]
From [www.prestonpct.nhs.uk] Last viewed: 25.06.2006
TRENDS IN MORTALITY FROM STOMACH CANCER (ICD10 C16, ICD9 151 adjusted):
INDIRECTLY STANDARDISED RATIOS (SMR), 1993 TO 2001 ANNUALLY, ALL AGES
(Standard rates are age-specific mortality rates in 2001)
SMRs for PCTs cannot be calculated for 1993 to 1997 as denominator data are not available
Figures for observed numbers (males and persons only) have been adjusted for 1993-1998 and 2000 to take into account ICD-10
MALES
FEMALES
PERSONS
1998
1999
2000
2001
1998
1999
2000
2001
1998
1999
2000
2001
ENGLAND AND WALES
SMR
120
115
106
100
117
109
101
100
119
112
104
100
OBS
4014
3886
3645
3490
2496
2309
2156
2158
6510
6195
5801
5648
ENGLAND
SMR
118
113
105
99
116
107
99
99
117
111
103 ...
[190]
Current status of Stomach cancer Screening in Korea
[545,8 KB]
From [www.cde.org.tw] Last viewed: 25.06.2006
cancer
1581
ICH E5 Guidance-Regulatory Point of View, Korea
Hoon-Kyo Kim, M.D.
Medical Oncology
St. Vincent’s Hospital
The Catholic University of Korea
APEC Taipei 2001
Korea FDA - New Concept ...
[191]
SMRs stomach cancer all ages 97-99 SMR data A B C D E F G H I J K ...
[153,1 KB]
From [www.ihs.ox.ac.uk] Last viewed: 25.06.2006
of the file http://www.ihs.ox.ac.uk/sepho/statistics/portrait/2000/Stomach_cancer/SMR_stomach_ca_allages.xls . G o o g l e automatically generates html versions of documents as we crawl the web. To link to or bookmark this page, use the following url: http://www.google.com/search?q=cache:Umth-HOKBHQJ:www.ihs.ox.ac.uk/sepho/statistics/portrait/2000/Stomach_cancer/SMR_stomach_ca_allages.xls+stomach+cancer+filetype:pdf+OR+filetype:doc+OR+filetype:ppt+OR+filetype:xls+OR+filetype:rtf&hl=it&ct=clnk&cd=194&lr=lang_en
Google is neither affiliated with the authors of this page nor responsible for its content.
These terms only appear in links pointing to this page: stomach cancer
1438
SMR data
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
1
Department of Health
...
[192]
Stomach Cancer In Ohio, 1998-2002
[340,8 KB]
From [www.odh.ohio.gov] Last viewed: 25.06.2006
Technical Note: Stomach cancer cases were defined as follows: International Classification of Diseases for Oncology,
Third Edition (ICD-O-3), codes C160-C169, excluding histology types 9590-9989.
Stomach Cancer
In Ohio, 1998-2002
This Report on
Stomach Cancer
Contains:
•
Incidence and Mortal-
ity in Ohio Compared
to the United States
•
Average Annual Case
Counts and Rates by
County of Residence
•
Age-adjusted Inci-
dence Rates by Gen-
der and Race
•
Proportion of Cases
and Survival by Stage
at Diagnosis and Gen-
der
•
Incidence Rates by
Gender and Race in
Ohio Compared to the
United States
•
Risk Factors
•
Sources of Data and
Additional Information
[
1] SEER: Surveillance, Epidemiology ...
[193]
Part six: Advanced cancer of the pancreas, prostate, stomach, and ...
[549,0 KB]
From [ajh.sagepub.com] Last viewed: 25.06.2006
MORTALITY FROM STOMACH CANCER BY PCT
Notes:
Mortality from stomach cancer (ICD10 C16):
Data are based on the original underlying cause of death.
Data are based on ONS population estimates (February 2005 release).
Highlights:
Bedfordshire Heartlands PCT and St Albans & Harpenden PCT both had a significantly lower ratio of stomach cancer
mortality than England
For More Information:
Please contact David Edwards, Cancer Lead, Public Health Intelligence Specialist, PHIU (david.edwards@phi-bedsherts.nhs.uk)
Page 2
Source: National Statistics, Compendium of Clinical and Health Indicators (Released 04/05)
Mortality from Stomach Cancer (SMR with 95% CI), 2001-2003 Pooled, All Ages
0
20
40
60
80
100
120
140
160
Bedford PCT
Bedfordshire
Heartlands PCT
Luton PCT
Dacorum PCT
Watford ...
[194]
Increased Risk of Neuroectodermal Tumors and Stomach Cancer in ...
From [jncicancerspectrum.oxfordjournals.org] Last viewed: 17.06.2006
[195]
Stomach cancer – some possible causes Page 1 Stomach cancer – some ...
[49,6 KB]
From [www.betterhealth.vic.gov.au] Last viewed: 17.06.2006
[196]
Stomach cancer
[312,3 KB]
From [www.healthpac.govt.nz] Last viewed: 17.06.2006
[197]
Stomach cancer
[312,3 KB]
From [www.healthpac.govt.nz] Last viewed: 17.06.2006
[198]
Garlic consumption and cancer prevention: meta-analyses of ...
[41,4 KB]
From [biblioteca.sp.san.gva.es] Last viewed: 17.06.2006
[199]
Stomach cancer mortality (SMR) all ages 2002-2004 by PCT.xls
[9,9 KB]
From [www.phi-bedsherts.nhs.uk] Last viewed: 17.06.2006
[200]
Stomach Cancer
[54,2 KB]
From [www.health.sa.gov.au] Last viewed: 17.06.2006
[201]
Incidence of Stomach Cancer in South Australia, 1991-2000 by ...
[170,8 KB]
From [www.health.sa.gov.au] Last viewed: 17.06.2006
[202]
Stomach Cancer Page 1 Although men have a higher incidence and ...
[54,2 KB]
From [www.dh.sa.gov.au] Last viewed: 17.06.2006
[203]
Stomach cancer in England_Cover.psd
[2439,7 KB]
From [www.uhce.ox.ac.uk] Last viewed: 17.06.2006
[204]
Cancer Incidence by Remoteness Category in Queensland : Cancer of ...
[6,1 KB]
From [www.health.qld.gov.au] Last viewed: 17.06.2006
[205]
No Apparent Association between NAT1 and NAT2 Genotypes and Risk ...
[21,1 KB]
From [dceg.cancer.gov] Last viewed: 17.06.2006
[206]
YLL stomach cancer up to 75 1997-99 YLL data A B C D E F G H I J K ...
[136,7 KB]
From [www.ihs.ox.ac.uk] Last viewed: 17.06.2006
[207]
SRRs stomach cancer all ages 92-94 SRR data A B C D E F G H I J K ...
[154,1 KB]
From [www.ihs.ox.ac.uk] Last viewed: 17.06.2006
[208]
STOMACH CANCER Page 1 STOMACH CANCER What Is Cancer? Cancer is a ...
[56,4 KB]
From [www.cancer.org] Last viewed: 17.06.2006
[209]
Load stomach cancer data by: Practical 2: Analysis of general ...
[135,2 KB]
From [stats.ma.ic.ac.uk] Last viewed: 17.06.2006
[210]
Stomach Cancer SMR all ages 96-98 SMR_Stomach_Ca A B C D E F G H I ...
[68,6 KB]
From [www.ihs.ox.ac.uk] Last viewed: 17.06.2006